FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102107385> ?p ?o ?g. }

• W2102107385 endingPage "618" @default.
• W2102107385 startingPage "606" @default.
• W2102107385 abstract "The myostatin/activin type II receptor (ActRII) pathway has been identified to be critical in regulating skeletal muscle size. Several other ligands, including GDF11 and the activins, signal through this pathway, suggesting that the ActRII receptors are major regulatory nodes in the regulation of muscle mass. We have developed a novel, human anti-ActRII antibody (bimagrumab, or BYM338) to prevent binding of ligands to the receptors and thus inhibit downstream signaling. BYM338 enhances differentiation of primary human skeletal myoblasts and counteracts the inhibition of differentiation induced by myostatin or activin A. BYM338 prevents myostatin- or activin A-induced atrophy through inhibition of Smad2/3 phosphorylation, thus sparing the myosin heavy chain from degradation. BYM338 dramatically increases skeletal muscle mass in mice, beyond sole inhibition of myostatin, detected by comparing the antibody with a myostatin inhibitor. A mouse version of the antibody induces enhanced muscle hypertrophy in myostatin mutant mice, further confirming a beneficial effect on muscle growth beyond myostatin inhibition alone through blockade of ActRII ligands. BYM338 protects muscles from glucocorticoid-induced atrophy and weakness via prevention of muscle and tetanic force losses. These data highlight the compelling therapeutic potential of BYM338 for the treatment of skeletal muscle atrophy and weakness in multiple settings." @default.
• W2102107385 created "2016-06-24" @default.
• W2102107385 creator A5001227863 @default.
• W2102107385 creator A5003137384 @default.
• W2102107385 creator A5003537466 @default.
• W2102107385 creator A5011596238 @default.
• W2102107385 creator A5021884298 @default.
• W2102107385 creator A5025137874 @default.
• W2102107385 creator A5031238323 @default.
• W2102107385 creator A5036454259 @default.
• W2102107385 creator A5040180511 @default.
• W2102107385 creator A5050105276 @default.
• W2102107385 creator A5054558716 @default.
• W2102107385 creator A5090111812 @default.
• W2102107385 date "2014-02-01" @default.
• W2102107385 modified "2023-10-11" @default.
• W2102107385 title "An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy" @default.
• W2102107385 cites W1527606515 @default.
• W2102107385 cites W1530473805 @default.
• W2102107385 cites W1586159393 @default.
• W2102107385 cites W1932610186 @default.
• W2102107385 cites W1967536924 @default.
• W2102107385 cites W1968413670 @default.
• W2102107385 cites W1971189666 @default.
• W2102107385 cites W1973743098 @default.
• W2102107385 cites W1979533069 @default.
• W2102107385 cites W1980771329 @default.
• W2102107385 cites W1981123666 @default.
• W2102107385 cites W1993983307 @default.
• W2102107385 cites W2003209022 @default.
• W2102107385 cites W2016989396 @default.
• W2102107385 cites W2023470228 @default.
• W2102107385 cites W2028026223 @default.
• W2102107385 cites W2029816532 @default.
• W2102107385 cites W2033924360 @default.
• W2102107385 cites W2034074403 @default.
• W2102107385 cites W2035555824 @default.
• W2102107385 cites W2047284298 @default.
• W2102107385 cites W2050592095 @default.
• W2102107385 cites W2050967224 @default.
• W2102107385 cites W2053079324 @default.
• W2102107385 cites W2053710837 @default.
• W2102107385 cites W2054368198 @default.
• W2102107385 cites W2061929833 @default.
• W2102107385 cites W2066821105 @default.
• W2102107385 cites W2081287636 @default.
• W2102107385 cites W2084480543 @default.
• W2102107385 cites W2095229526 @default.
• W2102107385 cites W2095627243 @default.
• W2102107385 cites W2097103188 @default.
• W2102107385 cites W2097171062 @default.
• W2102107385 cites W2099629426 @default.
• W2102107385 cites W2106719297 @default.
• W2102107385 cites W2114796514 @default.
• W2102107385 cites W2116082328 @default.
• W2102107385 cites W2127318580 @default.
• W2102107385 cites W2133847359 @default.
• W2102107385 cites W2134406094 @default.
• W2102107385 cites W2144203293 @default.
• W2102107385 cites W2149017968 @default.
• W2102107385 cites W2149030353 @default.
• W2102107385 cites W2149284281 @default.
• W2102107385 cites W2149993139 @default.
• W2102107385 cites W2151283204 @default.
• W2102107385 cites W2159760110 @default.
• W2102107385 cites W2160199212 @default.
• W2102107385 cites W2165868509 @default.
• W2102107385 cites W2166485013 @default.
• W2102107385 cites W2166877291 @default.
• W2102107385 cites W2166947475 @default.
• W2102107385 cites W2169362375 @default.
• W2102107385 doi "https://doi.org/10.1128/mcb.01307-13" @default.
• W2102107385 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3911487" @default.
• W2102107385 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24298022" @default.
• W2102107385 hasPublicationYear "2014" @default.
• W2102107385 type Work @default.
• W2102107385 sameAs 2102107385 @default.
• W2102107385 citedByCount "227" @default.
• W2102107385 countsByYear W21021073852013 @default.
• W2102107385 countsByYear W21021073852014 @default.
• W2102107385 countsByYear W21021073852015 @default.
• W2102107385 countsByYear W21021073852016 @default.
• W2102107385 countsByYear W21021073852017 @default.
• W2102107385 countsByYear W21021073852018 @default.
• W2102107385 countsByYear W21021073852019 @default.
• W2102107385 countsByYear W21021073852020 @default.
• W2102107385 countsByYear W21021073852021 @default.
• W2102107385 countsByYear W21021073852022 @default.
• W2102107385 countsByYear W21021073852023 @default.
• W2102107385 crossrefType "journal-article" @default.
• W2102107385 hasAuthorship W2102107385A5001227863 @default.
• W2102107385 hasAuthorship W2102107385A5003137384 @default.
• W2102107385 hasAuthorship W2102107385A5003537466 @default.
• W2102107385 hasAuthorship W2102107385A5011596238 @default.
• W2102107385 hasAuthorship W2102107385A5021884298 @default.
• W2102107385 hasAuthorship W2102107385A5025137874 @default.
• W2102107385 hasAuthorship W2102107385A5031238323 @default.
• W2102107385 hasAuthorship W2102107385A5036454259 @default.

• next